StockData
Amarin Corp PLC logo

Amarin Corp PLC (AMRN) stock

AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26−0.01 (-0.09%)

Close on Nov 18, 2026Market cap $248.90MP/E –Yield –

Amarin net income

Net income is the profit left for shareholders after every expense, interest and tax.

Amarin's net income for the twelve months ending Sep 30, 2026 was -$19.14M. For fiscal 2025 it was -$38.80M. The highest annual figure on record is $7.73M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$38.80M–
FY2024Dec 31, 2024-$82.18M–
FY2023Dec 31, 2023-$59.11M–
FY2022Dec 31, 2022-$105.80M-1468.9%
FY2021Dec 31, 2021$7.73M–
FY2020Dec 31, 2020-$18.00M–
FY2019Dec 31, 2019-$22.65M–
FY2018Dec 31, 2018-$116.45M–
FY2017Dec 31, 2017-$67.87M–
FY2016Dec 31, 2016-$86.35M–
FY2015Dec 31, 2015-$115.20M–
FY2014Dec 31, 2014-$56.36M–
FY2013Dec 31, 2013-$166.23M–
FY2012Dec 31, 2012-$179.18M–
FY2011Dec 31, 2011-$69.13M–
FY2010Dec 31, 2010-$249.59M–
FY2009Dec 31, 2009-$30.61M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$245.00K–
Q2 FY2026Jun 30, 2026-$7.65M–
Q1 FY2026Mar 31, 2026-$10.51M–
Q4 FY2025Dec 31, 2025-$1.22M–
Q3 FY2025Sep 30, 2025-$7.74M–
Q2 FY2025Jun 30, 2025-$14.14M-1029.0%
Q1 FY2025Mar 31, 2025-$15.70M–
Q4 FY2024Dec 31, 2024-$48.62M–
Q3 FY2024Sep 30, 2024-$25.13M–
Q2 FY2024Jun 30, 2024$1.52M–
Q1 FY2024Mar 31, 2024-$9.95M–
Q4 FY2023Dec 31, 2023-$5.78M-775.4%
Q3 FY2023Sep 30, 2023-$19.31M–
Q2 FY2023Jun 30, 2023-$17.56M–
Q1 FY2023Mar 31, 2023-$16.46M–
Q4 FY2022Dec 31, 2022$856.00K-94.2%
Q3 FY2022Sep 30, 2022-$5.14M–
Q2 FY2022Jun 30, 2022-$69.96M-996.0%
Q1 FY2022Mar 31, 2022-$31.56M–
Q4 FY2021Dec 31, 2021$14.70M+198.4%
Q3 FY2021Sep 30, 2021-$13.15M–
Q2 FY2021Jun 30, 2021$7.81M+76.9%
Q1 FY2021Mar 31, 2021-$1.63M–
Q4 FY2020Dec 31, 2020$4.93M-30.3%
Q3 FY2020Sep 30, 2020-$6.79M–
Q2 FY2020Jun 30, 2020$4.42M–
Q1 FY2020Mar 31, 2020-$20.55M–
Q4 FY2019Dec 31, 2019$7.07M–
Q3 FY2019Sep 30, 2019-$3.46M–
Q2 FY2019Jun 30, 2019-$1.82M–
Q1 FY2019Mar 31, 2019-$24.43M–
Q4 FY2018Dec 31, 2018-$33.67M–
Q3 FY2018Sep 30, 2018-$24.47M–
Q2 FY2018Jun 30, 2018-$34.21M–
Q1 FY2018Mar 31, 2018-$24.10M–
Q4 FY2017Dec 31, 2017-$22.47M–
Q3 FY2017Sep 30, 2017-$10.83M–
Q2 FY2017Jun 30, 2017-$13.63M–
Q1 FY2017Mar 31, 2017-$20.94M–
Q4 FY2016Dec 31, 2016-$27.45M–

More Amarin figures

See a number that looks wrong?